SANDS CAPITAL MANAGEMENT LLC 13D/13G Filings for Ultragenyx Pharmaceutical Inc. (RARE)

SANDS CAPITAL MANAGEMENT LLC 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-12
11:42 am
Purchase		 2024-12-31 13G Ultragenyx Pharmaceutical Inc.
RARE		 SANDS CAPITAL MANAGEMENT LLC 4,298,003
4.700%		 179,995increase
(+4.37%)		 Filing
2024-02-13
3:41 pm
Purchase		 2023-12-31 13G Ultragenyx Pharmaceutical Inc.
RARE		 SANDS CAPITAL MANAGEMENT LLC 4,118,008
5.000%		 4,118,008increase
(New Position)		 Filing